Scion Asset Management LLC Takes Position in Oscar Health, Inc. (NYSE:OSCR)

Scion Asset Management LLC bought a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 200,000 shares of the company's stock, valued at approximately $2,688,000. Oscar Health makes up about 3.5% of Scion Asset Management LLC's holdings, making the stock its 11th biggest holding. Scion Asset Management LLC owned approximately 0.08% of Oscar Health at the end of the most recent reporting period.A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Tower Research Capital LLC TRC increased its stake in Oscar Health by 171.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after acquiring an additional 4,185 shares during the last quarter. KBC Group NV grew its holdings in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after purchasing an additional 2,555 shares in the last quarter. Alberta Investment Management Corp purchased a new position in shares of Oscar Health in the fourth quarter valued at $138,000. Virtu Financial LLC bought a new stake in Oscar Health in the fourth quarter worth $140,000. Finally, Potentia Wealth purchased a new stake in Oscar Health during the fourth quarter valued at $141,000. Institutional investors own 75.70% of the company's stock. Oscar Health Price PerformanceShares of Oscar Health stock opened at $17.52 on Friday. The stock has a market cap of $4.39 billion, a price-to-earnings ratio of -875.31 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a 50 day moving average price of $13.46 and a 200-day moving average price of $14.66. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Oscar Health's revenue was up 42.2% on a year-over-year basis. During the same period last year, the company earned $0.62 earnings per share. Equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year. Insider ActivityIn other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 24.39% of the company's stock. Wall Street Analysts Forecast GrowthSeparately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price objective for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Oscar Health has an average rating of "Hold" and a consensus price target of $20.08.View Our Latest Stock Report on OSCROscar Health Profile (Free Report)Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.Featured StoriesFive stocks we like better than Oscar HealthWhat Are Dividend Challengers?Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold VisionHow the NYSE and NASDAQ are Different, Why That Matters to InvestorsRetail Investors Are Betting Big on Rocket Lab—Should You Too?Are Penny Stocks a Good Fit for Your Portfolio?GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth EngineThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Oscar Health Right Now?Before you consider Oscar Health, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here